Lactate levels as predictors of hospitalization in infants with acute bronchiolitis: a multicenter retrospective study

Background: Acute bronchiolitis (AB) is a common lower respiratory tract disease in infants and a major cause of emergency department visits and hospitalizations. Reliable biomarkers to predict hospitalization are needed because clear prognostic criteria are lacking. This study aimed to evaluate the predictive value of lactate levels for hospitalization in infants with AB. Methods: This retrospective observational study was conducted across three emergency medical centers in Korea from January 2020 to December 2022. A total of 234 infants diagnosed with AB were included. Demographic characteristics, vital signs, and laboratory results, including lactate levels, were collected and compared between discharged and hospitalized patients. Multivariable logistic regression and receiver operating characteristic (ROC) curve analyses were performed to identify significant predictors of hospitalization. Results: Lactate levels were significantly higher in the hospitalized group compared with the discharged group (2.00 vs. 1.70 mmol/L, p = 0.003). In multivariable analysis, lactate was identified as an independent predictor of hospitalization (odds ratio 1.718; 95% confidence interval 1.059–2.787). The ROC curve for lactate demonstrated an area under the curve of 0.628, indicating limited discriminative ability. Conclusions: Elevated lactate levels are associated with hospitalization in infants with AB; however, their predictive performance is modest. Larger, prospective studies are required to validate the clinical utility of lactate as a biomarker for risk stratification and decision-making in AB patients.

Acute bronchiolitis; Infant; Lactate measurement

[1] Rodríguez-González M, Estepa-Pedregosa L, Estalella-Mendoza A, Rodríguez-Campoy P, Romero-Castillo E, Castellano-Martínez A, et al. Routine laboratory test to assess the need of respiratory support in acute bronchiolitis. Pediatric Pulmonology. 2022; 57: 1339–1347.

[2] Alqahtani MH, Alqahtani MF, Asiri M, Alghamdi S, Alshagawi Z, Alzahrani S. Bronchiolitis in infants; five years’ experience of a teaching hospital. Infection and Drug Resistance. 2023; 16: 5647–5664.

[3] Willson DF, Horn SD, Hendley JO, Smout R, Gassaway J. Effect of practice variation on resource utilization in infants hospitalized for viral lower respiratory illness. Pediatrics. 2001; 108: 851–855.

[4] Hernández-Villarroel AC, Ruiz-García A, Manzanaro C, Echevarría-Zubero R, Bote-Gascón P, Gonzalez-Bertolin I, et al. Lung ultrasound: a useful prognostic tool in the management of bronchiolitis in the emergency department. Journal of Personalized Medicine. 2023; 13: 1624.

[5] Mehta R, Scheffler M, Tapia L, Aideyan L, Patel KD, Jewell AM, et al. Lactate dehydrogenase and caspase activity in nasopharyngeal secretions are predictors of bronchiolitis severity. Influenza and Other Respiratory Viruses. 2014; 8: 617–625.

[6] Virgili F, Nenna R, Di Mattia G, Matera L, Petrarca L, Conti MG, et al. Acute bronchiolitis: the less, the better? Current Pediatric Reviews. 2024; 20: 216–223.

[7] Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014; 134: e1474–e1502.

[8] Camporesi A, Morello R, Guzzardella A, Pierucci UM, Izzo F, De Rose C, et al. A combined rapid clinical and lung ultrasound score for predicting bronchiolitis severity. Intensive Care Medicine—Paediatric and Neonatal. 2023; 1: 14.

[9] Kogias C, Prountzos S, Alexopoulou E, Douros K. Lung ultrasound systematic review shows its prognostic and diagnostic role in acute viral bronchiolitis. Acta Paediatrica. 2023; 112: 222–232.

[10] Alejandre C, Guitart C, Balaguer M, Torrús I, Bobillo-Perez S, Cambra FJ, et al. Use of procalcitonin and C-reactive protein in the diagnosis of bacterial infection in infants with severe bronchiolitis. European Journal of Pediatrics. 2021; 180: 833–842.

[11] Rodríguez-González M, Estepa-Pedregosa L, Estalella-Mendoza A, Castellano-Martínez A, Rodríguez-Campoy P, Flores-González JC. Early elevated NT-proBNP but not troponin I is associated with severe bronchiolitis in infants. Clinica Chimica Acta. 2021; 518: 173–179.

[12] Rodríguez-González M, Castellano-Martínez A, Estalella-Mendoza A, Rodríguez-Campoy P, Estepa-Pedregosa L, Calero-Ruiz MM, et al. Correlation between urinary and serum NT-proBNP in acute bronchiolitis: a pilot study. Pediatric Pulmonology. 2023; 58: 492–499.

[13] Rajvanshi N, Kalyana PB, Kumar P, Goyal JP. Does urinary NT-proBNP have a role in predicting bronchiolitis severity? Pediatric Pulmonology. 2023; 58: 2462–2463.

[14] Wen H, Xia H, Tao F, Jin T, Liu Z, Dai H, et al. Prognostic value of serum total IgE and FeNO levels in children with atopic constitution bronchiolitis. Scientific Reports. 2024; 14: 21160.

[15] Xu X, Han W, Han W. Correlation analysis between serum total IgE and FeNO and idiosyncratic reaction in bronchiolitis. Clinics. 2024; 79: 100384.

[16] Roghani SA, Dastbaz M, Lotfi R, Shamsi A, Abdan Z, Rostampour R, et al. The development of anticyclic citrullinated peptide (anti-CCP) antibody following severe COVID-19. Immunity, Inflammation and Disease. 2024; 12: e1276.

[17] Florin TA, Plint AC, Zorc JJ. Viral bronchiolitis. The Lancet. 2017; 389: 211–224.

[18] Duarte-Dorado DM, Madero-Orostegui DS, Rodriguez-Martinez CE, Nino G. Validation of a scale to assess the severity of bronchiolitis in a population of hospitalized infants. Journal of Asthma. 2013; 50: 1056–1061.

[19] Ferres J. Inhalation therapy in the newborn. Anales Espanoles de Pediatría. 1992; 36: 160–163. (In Spanish)

[20] Gajdos V, Beydon N, Bommenel L, Pellegrino B, De Pontual L, Bailleux S, et al. Inter‐observer agreement between physicians, nurses, and respiratory therapists for respiratory clinical evaluation in bronchiolitis. Pediatric Pulmonology. 2009; 44: 754–762.

[21] Liu LL, Gallaher MM, Davis RL, Rutter CM, Lewis TC, Marcuse EK. Use of a respiratory clinical score among different providers. Pediatric Pulmonology. 2004; 37: 243–248.

[22] Marlais M, Evans J, Abrahamson E. Clinical predictors of admission in infants with acute bronchiolitis. Archives of Disease in Childhood. 2011; 96: 648–652.

[23] Rodriguez H, Hartert TV, Gebretsadik T, Carroll KN, Larkin EK. A simple respiratory severity score that may be used in evaluation of acute respiratory infection. BMC Research Notes. 2016; 9: 85.

[24] Rodriguez-Martinez CE, Sossa-Briceño MP, Nino G. Systematic review of instruments aimed at evaluating the severity of bronchiolitis. Paediatric Respiratory Reviews. 2018; 25: 43–57.

[25] Alnaji F, Zemek R, Barrowman N, Plint A. PRAM score as predictor of pediatric asthma hospitalization. Academic Emergency Medicine. 2014; 21: 872–878.

[26] Smith SR, Baty JD, Hodge III D. Validation of the pulmonary score: an asthma severity score for children. Academic Emergency Medicine. 2002; 9: 99–104.

[27] Hu XT, Wu XF, Xu JY, Xu X. Lactate-mediated lactylation in human health and diseases: progress and remaining challenges. Journal of Advanced Research. 2025; 75: 229–248.

[28] Luo Y, Li L, Chen X, Gou H, Yan K, Xu Y. Effects of lactate in immunosuppression and inflammation: progress and prospects. International Reviews of Immunology. 2022; 41: 19–29.

[29] Nygaard U, Dungu KHS, von Linstow ML, Lundstrøm K, Zhang H, Vissing NH. Lactate as a screening tool for critical illness in a pediatric emergency department. Pediatric Emergency Care. 2023; 39: 735–738.

[30] Scott HF, Lindberg DM, Brackman S, McGonagle E, Leonard JE, Adelgais K, et al. Pediatric sepsis in general emergency departments: association between pediatric sepsis case volume, care quality, and outcome. Annals of Emergency Medicine. 2024; 83: 318–326.

[31] Özel A, Erol EE, Yüce S, Büke Ö, Tahmiscioglu F, Erol M. Deciphering the role of lactate as a prognostic indicator in pediatric diabetic ketoacidosis. The Central European Journal of Medicine. 2025; 137: 98–104.

[32] Pérez MC, Fernández-Sarmiento J, Bustos JD, Ferro-Jackaman S, Ramírez-Caicedo P, Nieto A, et al. Association between the lactate-albumin ratio and microcirculation changes in Pediatric Septic patients. Scientific Report. 2024; 14: 22579.

[33] Zhang KY, Li PL, Yan P, Qin CJ, He H, Liao CP. The significance of admission blood lactate and fibrinogen in pediatric traumatic brain injury: a single-center clinical study. Child’s Nervous System. 2024; 40: 1207–1212.

[34] Ingelfinger JR, Kraut JA, Madias NE. Lactic acidosis. New England Journal of Medicine. 2014; 371: 2309–2319.

[35] Levy B, Desebbe O, Montemont C, Gibot S. Increased aerobic glycolysis through β2 stimulation is a common mechanism involved in lactate formation during shock states. Shock. 2008; 30: 417–421.

[36] Torres-Fernandez D, Casellas A, Mellado MJ, Calvo C, Bassat Q. Acute bronchiolitis and respiratory syncytial virus seasonal transmission during the COVID-19 pandemic in Spain: a national perspective from the pediatric Spanish Society (AEP). Journal of Clinical Virology. 2021; 145: 105027.